Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2005
10/13/2005US20050227934 Diabetes; DNA or RNA molecules comprising at least ten contiguous bases having a sequence in a pancreatic islet microRNA
10/13/2005US20050227933 Treatment of bacterial induced diseases using DNA methyl transferase inhibitors
10/13/2005US20050227924 Peyer's patch and/or M-cell targeting ligands
10/13/2005US20050227919 DNA damage repair inhibitors for the treatment of cancer
10/13/2005US20050227911 Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules
10/13/2005US20050227910 Local regional chemotherapy and radiotherapy using in situ hydrogel
10/13/2005US20050227285 Control of gene expression in eukaryotic cells
10/13/2005US20050227282 Human extracellular matrix-1
10/13/2005US20050227255 DLC-1 gene deleted in cancers
10/13/2005US20050227253 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
10/13/2005US20050227249 Polymorphisms in the human MDR-1 gene and their use in diagnostic and therapeutic applications
10/13/2005US20050227245 Reagents and methods for identifying and modulating expression of genes regulated by retinoids
10/13/2005US20050227233 Method for diagnosing and treating schizophrenia
10/13/2005US20050226934 Inclusion complexes of active compounds in acrylate (co)polymers and methods for their production
10/13/2005US20050226893 Lyophilization method to improve excipient crystallization
10/13/2005US20050226884 Using monoclonal antibody as diagnostic and therapeutic tool in treatment and prevention of cell proliferative and degenerative bone disorders; immunotherapy
10/13/2005US20050226869 inhibiting the growth of a cell that expresses a protein of the invention; antitumor agents; identify polypeptides, cell membrane-associated, secreted or intracellular polypeptides whose expression is specifically limited to only a single (or very limited number of different) tissue type(s)
10/13/2005US20050226866 Bone morphogenic protein specific immunoglobulin for treatment of bone diseases; immunotherapy
10/13/2005US20050226849 Compositions and methods of using capsid protein from Flaviviruses and Pestiviruses
10/13/2005US20050226848 Transcriptional regulation of gene expression by small double-stranded modulatory RNA
10/13/2005US20050226847 Adeno-associated virus producer system
10/13/2005CA2563117A1 Treatment of type 1 diabetes with inhibitors of macrophage migration inhibitory factor
10/13/2005CA2561978A1 Therapeutic molecules for modulating stability of vegf transcripts
10/13/2005CA2559853A1 Materials and methods for treatment of inflammatory and cell proliferation disorders
10/12/2005EP1584685A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination
10/12/2005EP1584682A1 Regulation of bcl-2 gene expression
10/12/2005EP1584628A2 Viral protein
10/12/2005EP1583971A2 Modulation of deubiquitinase family members
10/12/2005EP1583844A2 Modulation of pten expression via oligomeric compounds
10/12/2005EP1583834A1 Gene expression inducing fusion protein and method for controlling gene expression induction
10/12/2005EP1583826A2 Inhibition of e3-ubiquitin ligase hakai for treatment of proliferative disorders
10/12/2005EP1583782A2 Cationic graft-copolymer for non-viral gene delivery vector
10/12/2005EP1583560A1 Composition for intracellular transport of biological particles or macromolecules
10/12/2005EP1583504A2 Methods and compositions for the diagnosis, prognosis, and treatment of cancer
10/12/2005EP1583502A2 Methods and reagents for the enhancement of virus transduction in the bladder epithelium
10/12/2005EP1583500A2 Methods and compositions for inducing immune responses and protective immunity by priming with alphavirus replicon vaccines
10/12/2005EP1583422A2 Cell-based therapies for ischemia
10/12/2005EP1305410B1 Insulin producing cell-line obtained by electrofusion
10/12/2005EP1294918B1 Replication deficient adenoviral tnf vector
10/12/2005EP1272666B1 A functional assay of high-density lipoprotein
10/12/2005EP1259814B1 Bcmp-7 as marker for diagnosis of breast cancer
10/12/2005EP1049793B1 Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications
10/12/2005EP0556345B2 Retroviral vectors useful for gene therapy
10/12/2005CN1682111A Diagnosing tumorigenicity and determining resistance to the antineoplastic therapy
10/12/2005CN1681838A Nogo受体拮抗剂 Nogo receptor antagonist
10/12/2005CN1681528A Use of urease for inhibiting cancer cell growth
10/12/2005CN1680557A Penicillium marneffei CRG5 gene, its coding protein and use
10/12/2005CN1680555A Penicillium marneffei 60S ribosomal protein L33-B, its coding sequence and use
10/12/2005CN1680554A Penicillium marneffei thymus resistant glubolin, its coding sequence and use
10/12/2005CN1680451A Immune responses against HPV antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins
10/12/2005CN1680442A Truncated VEGF-related proteins
10/12/2005CN1680434A Streptococcus pneumoniae antigens
10/12/2005CN1680432A Viral protein
10/12/2005CN1679966A Nanometer grainy and mucosal immunity of antiatherosclerosis nucleic vaccine
10/12/2005CN1679965A Spleen target directional DNA delivering system
10/12/2005CN1679964A Antisense nucleic acid medicine composition with bcr3/abl2 and VEGF gene function inhibition and use thereof
10/12/2005CN1679930A Human papilloma virus and heat shock protein recombinant protein vaccine and use thereof
10/12/2005CN1679929A Streptococcal c5a peptidase vaccine
10/12/2005CN1679641A Use of tumor treating of recombinant adenoviral P53 products
10/12/2005CN1222619C Method of enhancing immune responses to herpes simplex virus vaccine and its pharmaceutical use
10/11/2005US6953834 Transcription factors related to TFIIA
10/11/2005US6953778 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
10/11/2005US6953690 Compositions and methods for helper-free production of recombinant adeno-associated viruses
10/11/2005US6953670 Methods for identifying compounds capable of supplementing the biological activity of leptin
10/11/2005US6953667 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of autoimmune disease
10/11/2005US6953662 Follistatin-3
10/11/2005US6953575 Methods of treating central nervous system disorders using viral vectors
10/11/2005US6953568 Administering biological conjugates that bind preferentially to endothelial protein C receptor(EPCR), to endothelial cells of vascular systems; genetic translocation; drug delivery
10/06/2005WO2005093427A1 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 50 (gpr50)
10/06/2005WO2005093098A1 Differential drug sensitivity
10/06/2005WO2005093082A1 Method of screening compound capable of accelerating or inhibiting apoptosis, apoptosis accelerator and apoptosis inhibitor
10/06/2005WO2005093067A1 Decoy nucleic acid to synoviolin gene promoter
10/06/2005WO2005093064A1 Novel galectin 9 modification protein and use thereof
10/06/2005WO2005093063A1 Kit for solid cancer diagnosis and medicine for solid cancer therapy
10/06/2005WO2005093057A1 Truncated dance, dance complex and method of using these
10/06/2005WO2005092924A2 Rab9a, rab11a, and modulators thereof related to infectious disease
10/06/2005WO2005092394A1 siRNA CAPABLE OF INHIBITING EXPRESSION OF WT1 GENE AND USE THEREOF
10/06/2005WO2005092393A1 Micro rna inhibiting the expression of wt1 gene and utilization of the same
10/06/2005WO2005092383A1 Preventive/remedy for respiratory diseases
10/06/2005WO2005092069A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
10/06/2005WO2005092033A2 Preventing arrhythmias associated with cell transplantation
10/06/2005WO2005091992A2 Oligonucleotide compositions targeting egr-1 forcancer treatment
10/06/2005WO2005091716A2 Annexin ii and uses thereof
10/06/2005WO2005077126A9 Use of ppargamma specific inhibitors as anti-cancer therapeutics
10/06/2005WO2005072893A8 Functionalized colloidal metal compositions and methods
10/06/2005WO2005072261A3 Lactoferrin-treated filament materials
10/06/2005WO2005068630A8 Double-stranded rna for interference
10/06/2005WO2005049838A3 Syk-targeted nucleic acid interference
10/06/2005WO2005027844A3 Dna vaccine compositions and methods of use
10/06/2005WO2005026388A3 The use of eukaryotic genes affecting chromatin separation for diagnosis and treatment of proliferative diseases
10/06/2005WO2005007877A3 Regulatable promoters for synthesis of small hairpin rna
10/06/2005WO2004098499A3 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
10/06/2005WO2004080406A3 Therapeutic compositions
10/06/2005WO2004069207A3 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins
10/06/2005WO2004041193A3 HUMAN TYPE II DIABETES GENE-Kv CHANNEL-INTERACTING PROTEIN (KChIP1) LOCATED ON CHROMOSOME 5
10/06/2005WO2004032877A3 Compositions, organisms and methodologies employing a novel human kinase
10/06/2005US20050222390 The peptide having the ability to bind to a molecule of human major histocompatibility complex class-I; use in immunotherapy of tumor-associated diseases and/or adenomatous diseases
10/06/2005US20050222386 Biomolecule transduction motif sim-2-btm and the use thereof
10/06/2005US20050222075 Process for delivering nucleic acids to cardiac tissue
10/06/2005US20050222074 Modulators of bone homeostasis identified in a high-throughput screen
1 ... 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 ... 870